 <h1>Congratulations! 🎉 </h1>
    <p style="color:#637381;">All done! You’ve completed another milestone.</p>

To continue, enter your details to log in.

We’ve sent a 6‑digit code to #MAIL_ADDRESS#\nPlease check your inbox or spam folder and enter the code below to continue.

Verification code sent

Thank you for the payment. You can now access {collectionName} by simply clicking the button below.

Yes, you’ve successfully ordered! 🎉

Unlock This Exclusive Course

It seems that your email address is not currently on the authorized access list. Please ensure you are using the email address that was invited, or contact the content owner for assistance.

Verification Required for Access

Course Introduction and Overview

What This Course Is About

Who This Mini-Course Is For

Teaching Goals (Learning Objectives)

Core Concepts and Toxicological Rationale

Slide 1 — Opening Hook (45 sec)

Slide 2 — Concept Simplified (60 sec)

Case Studies and Practical Implementation

Slide 3 — Case Study with Characters (90 sec)

Slide 4 — Practical Application (60 sec)

Compliance, Best Practices, and Review

Slide 5 — Knowledge Check + Takeaways (45 sec)

Part C — Top 5 Takeaways

10-Point Audit / Inspection-Readiness Checklist

Quiz

Part A — Quiz (Scenario 1)

Part A — Quiz (Scenario 2)

Part A — Quiz (Scenario 3)

Part A — Quiz (Scenario 4)

Part A — Quiz (Scenario 5)

Survey/Feedback

Part B — Reflection

Quality Review Confirmation

Welcome to the definitive course on "Applying the Permitted Daily Exposure Concept per ICH Q3C(R9)". In the highly regulated pharmaceutical manufacturing industry, ensuring patient safety while maintaining operational efficiency is paramount.

Welcome to the definitive course on "Applying the Permitted Daily Exposure Concept per ICH Q3C(R9)". In the highly regulated pharmaceutical manufacturing industry, ensuring patient safety while maintaining operational efficiency is paramount. This comprehensive mini-course is designed to demystify the Permitted Daily Exposure (PDE) concept, providing you with the toxicological rationale and practical workflows required for residual solvent compliance. Under the ICH Q3C(R9) guidelines, understanding how to calculate and apply PDE limits—rather than relying solely on detection limits or process capabilities—is critical for regulatory success. Throughout this course, you will explore the baseline requirements for residual solvent compliance, distinguish between a solvent's classification and its numerical limit, and dive deep into the core components of PDE calculations, including NOAEL, body-weight basis, and modifying factors (F1-F5). We will guide you through real-world case studies, comparing Option 1 and Option 2 pathways for standard and high-dose drug products. By analyzing borderline situations and common compliance errors, you will learn how to make risk-based, defensible decisions during batch disposition and specification setting. Whether you are looking to enhance your inspection readiness with our 10-point audit checklist or want to build robust, documented limit justifications, this course equips you with the actionable knowledge needed to protect patient safety and support continuous quality improvement. Join us to master the ICH Q3C(R9) PDE requirements and elevate your pharmaceutical compliance expertise today.

129. Applying the Permitted Daily Exposure Concept per ICH Q3C(R9)

<div class="simple-box-wrapper">
    <div class="simple-box">
        <div class="column">
            <p>The Permitted Daily Exposure (PDE) concept, as delineated in the ICH Q3C(R9) guideline, serves as the foundational toxicological threshold for establishing safe residual solvent limits in pharmaceutical manufacturing. For cross-functional professionals across Quality Assurance, Quality Control, Manufacturing, and Regulatory Affairs, a rigorous understanding of this framework is imperative for ensuring patient safety and maintaining strict regulatory compliance. This course provides a comprehensive examination of the PDE methodology, clearly distinguishing between a solvent's hazard classification and its numerical limit. By exploring the underlying toxicological rationale—including No Observed Adverse Effect Levels (NOAEL), body-weight assumptions, and modifying factors—learners will acquire the technical proficiency required to translate a theoretical PDE value (mg/day) into actionable, scientifically defensible specification limits used during batch disposition and analytical testing.</p>

<p>Moving beyond theoretical principles, the curriculum emphasizes practical implementation, risk-based decision-making, and continuous inspection readiness. Participants will engage with real-world case studies to navigate complex manufacturing scenarios, such as evaluating borderline batch results and determining the most appropriate calculation pathways (Option 1 versus Option 2) for high-dose drug products. The material is specifically tailored to address the operational realities of diverse departments, from engineers optimizing drying endpoints to regulatory authors justifying residual solvent limits in Module 3 (3.2.S.3.2, 3.2.P.5) submissions. Furthermore, the course equips professionals with a robust 10-point audit checklist and highlights common compliance pitfalls, ensuring that all limit justifications are fully traceable to the current ICH Q3C(R9) revision and capable of withstanding rigorous scrutiny during regulatory inspections.</p>
        </div>
    </div>
</div>
